Clinical Trial Update: Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia [Phase 2]

View source ↗

Summary

The Phase 2 pilot study of Hemospan in patients with chronic critical limb ischemia has completed. The trial was sponsored by Sangart.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Hemospan

Snippet

Sponsor: Sangart | Conditions: Vascular Disease, Critical Lower Limb Ischemia | Phase 2 | Status: COMPLETED